Do you want to read an article? Please log in or register.
Novel CAC Dispersion and Density Score to Predict Myocardial Infarction and Cardiovascular Mortality
Myocardial Infarction
Related content
Heart, Artery and Coronary Diseases
Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trials
Eur J Heart Fail
Foà A, Pabon MA, Braunwald E, Jering K, Vaduganathan M, Claggett BL, Køber L, Lewis EF, Granger CB, van der Meer P, Rouleau JL, Maggioni AP, McMurray JJV, Solomon SD, Pfeffer MA
doi: 10.1002/ejhf.3557
RECOMMENDED
Myocardial Infarction
Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
J Am Coll Cardiol
Leosdottir M, Schubert J, Brandts J, Gustafsson S, Cars T, Sundström J, Jernberg T, Ray KK, Hagström E
doi: 10.1016/j.jacc.2025.02.007
Myocardial Infarction
Association of sodium-glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis
Cardiovasc Diabetol
Maremmani M, Ebrahimi R, Centola M, Achilli F, Capone V, Bossone E, Templin C, Di Vece D
doi: 10.1186/s12933-025-02592-0
Myocardial Infarction
Drivers of 1-year mortality decline after acute myocardial infarction in England and Wales: a 15-year national cohort study
Heart
Ayayo SA, Martin GP, Zghebi S, Taxiarchi VP, Rashid M, Kontopantelis E, Mamas MA
doi: 10.1136/heartjnl-2024-325474
Cardiovascular Risk and Diseases
Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife
JAMA Cardiol
Jhee JH, Ha KH, Son D, Lee HH, Kim EJ, Kim HC, Lee H
doi: 10.1001/jamacardio.2025.3269
Myocardial Infarction
Mineralocorticoid Receptor Antagonists in Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Trials
JACC Heart Fail
d'Entremont MA, Cheema Z, Pitt B, Kedev S, Cornel JH, Stankovic G, Moreno R, Storey R, Bossard M, Chauhan A, Montalescot G, Beygui F, Zannad F, Jolly S, Mineralocorticoid Antagonist Post Myocardial Infarction Trialist Collaboration
doi: 10.1016/j.jchf.2025.102531
Myocardial InfarctionFurther Publications
Sex-Specific Association of Myocardial Fibrosis With Mortality in Patients With Aortic Stenosis
JAMA Cardiol
Kwak S, Singh A, Everett RJ, Treibel TA, Lim J, Won S, Williams MC, Loganathan K, Bing R, Craig N, Singh T, Joshi S, Lee H, Lee W, Kim YJ, Chin CWL, Fukui M, Al Musa T, Rigolli M, Tastet L, Dobson LE, Wiesemann S, Ferreira VM, Captur G, Lee S, Schulz-Menger J, Schelbert EB, Clavel MA, Park SJ, Pellegrini C, Hadamitzky M, Gerber BL, Newby DE, Myerson SG, Pibarot P, Cavalcante JL, McCann GP, Greenwood JP, Moon JC, Dweck MR, Lee SP
doi: 10.1001/jamacardio.2024.5593
Cardiovascular Risk and Diseases
Expanded Field OCTA Biomarkers Associated with Future Cardiovascular Disease and Mortality in Patients with Diabetic Retinopathy
Retina
Lu ES, Cui Y, Phu KK, Ding X, Nodecker KN, Le R, Zhu Y, Garg I, Baldwin G, Rodriguez J, Finn MJ, Razavi P, Laíns I, Wu DM, Husain D, Kim LA, Patel NA, Vavvas DG, Miller JB
doi: 10.1097/IAE.0000000000004695
Cardiovascular Risk and Diseases
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Lancet Diabetes Endocrinol
Aggarwal R, Bhatt DL, Szarek M, Cannon CP, Leiter LA, Inzucchi SE, Lopes RD, McGuire DK, Lewis JB, Riddle MC, Davies MJ, Banks P, Carroll AK, Scirica BM, Ray KK, Kosiborod MN, Cherney DZI, Udell JA, Verma S, Mason RP, Pitt B, Steg PG
doi: 10.1016/S2213-8587(24)00362-0